SAS Output

18-JUN-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1067 14 730 65 791 126 767
ERLYTX 465 3 157 19 231 72 438
GI 206 2 104 5 61 12 73
GU 307 5 261 20 244 52 317
LEUK 60 6 313 15 183 23 140
LUNG 290 2 104 10 122 28 170
LYMPH 16 1 52 2 24 6 37
MELAN 343 1 52 9 110 17 103
MMYEL 86 0 0 2 24 12 73
OTHER 44 0 0 5 61 11 67
SXQOL 4 1 52 3 37 3 18
Total 2888 35 1825 155 1888 362 2203

18-JUN-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 0 0 0 0 1 6
BREAST 165 7 365 33 402 78 475
CCD 1564 27 1409 114 1388 241 1467
LEUK 8 1 52 1 12 2 12
LUNG 612 7 365 56 682 118 718
PREV 85 0 0 3 37 6 37
SURV 97 1 52 7 85 11 67
SXQOL 5 0 0 0 0 0 0
Total 2537 43 2243 214 2606 457 2782

18-JUN-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 0 0 0 0 1 6
BREAST 1232 21 1096 98 1193 204 1242
CCD 1564 27 1409 114 1388 241 1467
ERLYTX 465 3 157 19 231 72 438
GI 206 2 104 5 61 12 73
GU 307 5 261 20 244 52 317
LEUK 68 7 365 16 195 25 152
LUNG 902 9 470 66 804 146 889
LYMPH 16 1 52 2 24 6 37
MELAN 343 1 52 9 110 17 103
MMYEL 86 0 0 2 24 12 73
OTHER 44 0 0 5 61 11 67
PREV 85 0 0 3 37 6 37
SURV 97 1 52 7 85 11 67
SXQOL 9 1 52 3 37 3 18
Total 5425 78 4070 369 4494 819 4986

18-JUN-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 578 8 417 42 511 85 517
ERLYTX 292 2 104 8 97 42 256
GI 134 2 104 4 49 11 67
GU 219 3 157 13 158 35 213
LEUK 42 2 104 8 97 14 85
LUNG 206 2 104 8 97 21 128
LYMPH 15 1 52 2 24 6 37
MELAN 174 1 52 8 97 12 73
MMYEL 86 0 0 2 24 12 73
OTHER 44 0 0 5 61 11 67
SXQOL 4 1 52 3 37 3 18
Total 1794 22 1146 103 1252 252 1534

18-JUN-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 0 0 0 0 1 6
BREAST 165 7 365 33 402 78 475
CCD 1120 23 1200 84 1023 174 1059
LEUK 8 1 52 1 12 2 12
LUNG 422 3 157 34 414 70 426
PREV 68 0 0 1 12 4 24
SURV 61 1 52 6 73 10 61
SXQOL 5 0 0 0 0 0 0
Total 1850 35 1826 159 1936 339 2063

18-JUN-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 0 0 0 0 1 6
BREAST 770 19 991 72 877 167 1017
CCD 1120 23 1200 84 1023 174 1059
ERLYTX 292 2 104 8 97 42 256
GI 156 2 104 9 110 19 116
GU 219 3 157 13 158 35 213
LEUK 54 3 157 9 110 18 110
LUNG 628 5 261 42 511 91 554
LYMPH 11 1 52 2 24 3 18
MELAN 169 1 52 8 97 12 73
MMYEL 86 0 0 2 24 12 73
OTHER 56 0 0 5 61 12 73
PREV 68 0 0 1 12 4 24
SURV 61 1 52 4 49 10 61
SXQOL 9 0 0 3 37 3 18
Total 3700 60 3130 262 3190 603 3671

18-JUN-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 854 9 470 46 560 86 524
ERLYTX 435 3 157 18 219 67 408
GI 148 1 52 3 37 5 30
GU 257 4 209 15 183 43 262
LEUK 35 6 313 13 158 17 103
LUNG 224 1 52 7 85 19 116
LYMPH 6 1 52 1 12 2 12
MELAN 328 1 52 9 110 17 103
MMYEL 1 0 0 1 12 1 6
Total 2288 26 1357 113 1376 257 1564

18-JUN-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1462 13 678 81 986 208 1266
AFFIL 165 7 365 29 353 63 384
CCOP/NCORP 2017 37 1931 152 1851 320 1948
Non-SWOG 1778 18 939 104 1266 225 1370
Total 5422 75 3913 366 4456 816 4968

18-JUN-2018 6:10

STUDIES OPENED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
SURV S1316 Compar. Effectiv. Trial for MBO 1 Y 02-JUN-18

18-JUN-2018 6:10

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Registrations
CCD S1415CD TrACER CSF Standing Order Intervention for FN 1 23
BREAST A011401 Breast, adj, Stage II/III HER2-, weight loss 2 6
BREAST EA1151 Brst, Tomosynthesis Mammographic Screening 1 6
BREAST S1207 Brst,Adj,Endocrine+/-Everolimus 1 6
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 6
LEUK S1612 AML/MDS, Age 60+, Aza/Novel Therapeutics 2 6
LEUK S1612 AML/MDS, Age 60+, Aza/Novel Therapeutics 1 6
LUNG S1400 SCCA,Adv, Biomarker Master 1 4
LUNG A151216 ALCHEMIST0 - screening 1 3
LUNG A151216 ALCHEMIST0 - screening 0 3
LUNG S1400 SCCA,Adv, Biomarker Master 2 3
CCD S1417CD Colorectal, Cost Cohort Study 1 3
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 2 3
ERLYTX S1609 Rare Tumor, Comb Nivo/Ipi 1 3